OrrLab
@Orr_Lab
Orr Lab at WashU | PI: Miranda Orr, PhD | Lab Interests: Aging, Alzheimer's disease, Neurodegenerative disorders, Tau, and Senescence
You might like
Congratulations to the 10 Goodes Prize winners who along with the ADDF have shaped the last decade of #Alzheimers research around the #biologyofaging, moving the field closer to treating the disease with #precisionmedicine. Hope is here. bit.ly/3B9HPTG
NanoString is excited to announce it will be acquired by Bruker Corporation in a $392.6 million agreement. We are grateful for our dedicated employees and customers! #futurelooksbright! bit.ly/3vMCkbz
Thank you @TheADDF for bringing together at#ADPD2024 this impactful roundtable on Novel Approches in AD Research guided by the Biology of Aging with @MiiaKivipelto @jacques_touchon @a_hfillit Miranda Orr @WakeForest @DrJeffCummings
TO ALL #spatial #genomics CEOs! Please read our Comment @GENbio “Sounding an Alarm over Spatial Biology” Scientists’ call for action. We are all part one community and have to act accordingly. Don’t let financial interests ruin innovation. genengnews.com/topics/biopers…
.@nanostringtech is here to stay! Joe Beechem speaks up @GENbio: “We are not going anywhere”. Only #diversity will drive #innovation in Spatial Genomics! #youarenotalone genengnews.com/topics/omics/n…
I'm curio-s, it may be time to parse on 10x?
Hot damn!! 10X is suing everyone in spatial and single cell. I was googling for the latest in Curio...
It has been fun working with @RCFNeuro, @alzassociation, @CurePSP and other organizers to develop the scientific program for #Tau2024! My lab will be there - will yours? March 25-26, 2024 in Washington, DC. Register now: alz.org/Tau
Thrilled to help @jme_walker and her team explore differences in NFTs between #PART and #AD using GeoMx DSP! Awesome work! #nanostrung
#Spatialproteomics reveal mechanisms of development and progression in #Alzheimer'sdisease. 🧠 👉bit.ly/3ZL5zWK @Orr_lab from Wake Forest University used GeoMx DSP to show proteome differences at the basis of Aβ and p-tau distribution and pathogenicity. #Fridayread
Happy to share our latest publication - we used spatial proteomics to compare #PART and #AD looking at differences between NFTs, normal neurons and their microenvironments in the CA1 and CA2 subregions of the #hippocampus, as well as the entorhinal cortex. doi.org/10.1002/alz.13…
🧟 The @Orr_Lab is researching senescent cells and their impact on memory problems. Could targeting "zombie" cells be a breakthrough in #Alzheimers treatments? Learn more: brnw.ch/21wD7Hq
ADDF-funded @Orr_Lab's #CombinationTherapy clinical trial on senescent cells supports the ADDF's core belief that the next generation of #Alzheimers drugs will be guided by #novel targets based on the #BiologyOfAging. More on the trial in @mcknightsltcn: bit.ly/3rgc2Mq
Last week's 9th Annual Melvin R. Goodes Prize Luncheon & symposium reflected on recent breakthroughs in #Alzheimers research. This year, the ADDF honored DxA-funded scientist, Dr. Rhoda Au for her work with #DigitalBiomarkers and #diagnostics for early Alzheimer's detection.
First feasibility study of orally-delivered #senolytic therapy in #Alzheimersdisease reports favorable safety data and penetrance of #dasatinib into the brain with a modest impact on Alzheimer’s and aging biomarkers @wakeforestmed @MitziMGonzales @Orr_Lab nature.com/articles/s4159…
Research from @Orr_Lab shows that treatment to clear #senescent cells in #Alzheimer’s disease is safe in Phase I clinical trial. Learn more about the study, which appears in @NatureMedicine. @TheADDF @nanostringtech brnw.ch/21wCn5E
Results from a new study led by ADDF-funded @Orr_Lab further validate that novel approaches to #Alzheimers centered around the biology of aging will guide the next generation of therapeutics. Read our statement on the senescent cell treatment study here: bit.ly/3RdEQjd
Exciting news! Led by @MitziGonzales, our team’s Phase I trial testing #senolytics in #Alzheimer’s disease reports on brain penetrance, safety, and biomarkers! 🧠 Phase 2 trial supported by @TheADDF is underway! #JoinOurStudy #SToMP-AD #Senescence #Aging nature.com/articles/s4159…
A fun day 1 at #AAIC23 with @theREALaivisaur @bbonakda @MaggieFlanagan @Orr_Lab @JohnCraryMDPHD ☺️🧠🍨
Thank you to all who joined the NSC Directors Symposium at #AGE2023! The session featured presentations from pilot grantees George Sutphin @senmorteco, Miranda Orr @Orr_Lab, Andrey Parkhitko, Anna @ThalackerMercer, Danielle Bruns, @SimoneSidoli, @MariaMMihaylova, & @CristalM_Hill
More than 6.7M Americans and 57M people worldwide are living with #Alzheimers today. A new gift from the #Lauders ensures the #ADDF will be able to continue funding the most promising science around the globe until we defeat this disease: bit.ly/3G3gNNG
Within the next 15 years, ADDF will help bring to market a new generation of drugs based on the #biologyofaging that can be combined with other therapies, including anti-amyloids, to defeat #Alzheimers thanks to a historic gift from the #Lauder family: bit.ly/3G3gNNG
United States Trends
- 1. Jets 57.6K posts
- 2. Henderson 17.3K posts
- 3. Justin Fields 5,250 posts
- 4. Drake Maye 13.1K posts
- 5. AD Mitchell 1,855 posts
- 6. Patriots 124K posts
- 7. Judge 169K posts
- 8. Cal Raleigh 5,887 posts
- 9. Diggs 7,163 posts
- 10. Purdue 8,366 posts
- 11. Pats 11.8K posts
- 12. #911onABC 14.7K posts
- 13. #TNFonPrime 2,432 posts
- 14. Braden Smith 1,395 posts
- 15. #TNAiMPACT 4,393 posts
- 16. AL MVP 15.5K posts
- 17. John Metchie N/A
- 18. Mack Hollins 2,459 posts
- 19. #JetUp 1,787 posts
- 20. #NYJvsNE 1,650 posts
You might like
-
Prof. Melissa E. Murray 📸🔬
@DrNeuroChic -
ISTAART
@ISTAART -
Gan Lab
@LiGanLab -
Iberoamerican ICSA
@Ibero_ICSA -
jpreventionalzheimer
@jpreventionalz1 -
Bess Frost
@bess_frost -
Nathan Shock Centers
@NathanShockCtrs -
John Fryer, PhD
@johnthefryer -
Angela Jefferson
@AJtheScientist -
CCAD
@The_CCAD -
Dr. Kimberly Raab Graham
@raabgraham_lab -
Sara Espinoza
@sessi73
Something went wrong.
Something went wrong.